124 related articles for article (PubMed ID: 36603379)
21. Success of salvage treatment: a critical appraisal of salvage rates for different subsites of HNSCC.
Matoscevic K; Graf N; Pezier TF; Huber GF
Otolaryngol Head Neck Surg; 2014 Sep; 151(3):454-61. PubMed ID: 24894422
[TBL] [Abstract][Full Text] [Related]
22. Cyclo-oxygenase-2 Expression Is Associated With Lymph Node Metastasis in Oropharyngeal Squamous Cell Carcinoma Under the New TNM Classification.
Sekimizu M; Ozawa H; Saito S; Ikari Y; Nakahara N; Nakamura S; Yoshihama K; Ito F; Watanabe Y; Imanishi Y; Kameyama K; Ogawa K
Anticancer Res; 2019 Oct; 39(10):5623-5630. PubMed ID: 31570459
[TBL] [Abstract][Full Text] [Related]
23. Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
Lee J; Chang JS; Kwon HJ; Kim SH; Shin SJ; Keum KC
Jpn J Clin Oncol; 2016 Oct; 46(10):911-918. PubMed ID: 27474125
[TBL] [Abstract][Full Text] [Related]
24. The Indications for Elective Neck Dissection in T1N0M0 Oral Cavity Squamous Cell Carcinoma.
Nguyen E; McKenzie J; Clarke R; Lou S; Singh T
J Oral Maxillofac Surg; 2021 Aug; 79(8):1779-1793. PubMed ID: 33744243
[TBL] [Abstract][Full Text] [Related]
25. Muscle invasion in oropharyngeal carcinoma undergoing transoral robotic surgery.
McKenzie RM; Parhar HS; Ng TL; Prisman E
Head Neck; 2021 Apr; 43(4):1194-1201. PubMed ID: 33355962
[TBL] [Abstract][Full Text] [Related]
26. A comparison of oncological outcomes between transoral surgical and non-surgical treatment protocols in the management of oropharyngeal squamous cell carcinoma.
Kao SS; Micklem J; Ofo E; Edwards S; Dhatrak D; Foreman A; Krishnan S; Hodge JC
J Laryngol Otol; 2018 Apr; 132(4):349-355. PubMed ID: 28480836
[TBL] [Abstract][Full Text] [Related]
27. The accuracy of clinical neck staging for p16-positive and negative oropharyngeal cancer and its therapeutic implications.
Hussain T; Thangavelu K; Kürten C; Galland L; Höing B; Deuss E; Mattheis S; Lang S; Deuschl C; Forsting M; Dörner N
Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5339-5345. PubMed ID: 35781741
[TBL] [Abstract][Full Text] [Related]
28. Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.
Cracchiolo JR; Baxi SS; Morris LG; Ganly I; Patel SG; Cohen MA; Roman BR
Cancer; 2016 May; 122(10):1523-32. PubMed ID: 26970050
[TBL] [Abstract][Full Text] [Related]
29. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
30. High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma.
Haque S; Karivedu V; Riaz MK; Choi D; Roof L; Hassan SZ; Zhu Z; Jandarov R; Takiar V; Tang A; Wise-Draper T
Oral Oncol; 2019 Jan; 88():9-15. PubMed ID: 30616803
[TBL] [Abstract][Full Text] [Related]
31. Association of Positive Initial Margins With Survival Among Patients With Squamous Cell Carcinoma Treated With Total Laryngectomy.
Tassone P; Savard C; Topf MC; Keane W; Luginbuhl A; Curry J; Cognetti D
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1030-1036. PubMed ID: 30054637
[TBL] [Abstract][Full Text] [Related]
32. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
[TBL] [Abstract][Full Text] [Related]
34. Survival outcomes following salvage surgery for oropharyngeal squamous cell carcinoma: systematic review.
Kao SS; Ooi EH
J Laryngol Otol; 2018 Apr; 132(4):299-313. PubMed ID: 28502256
[TBL] [Abstract][Full Text] [Related]
35. Pathologically determined tumor volume vs pathologic T stage in the prediction of outcome after surgical treatment of oropharyngeal squamous cell carcinoma.
Nixon IJ; Palmer FL; Lakin P; Kattan MM; Lee NY; Ganly I
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1151-5. PubMed ID: 24092047
[TBL] [Abstract][Full Text] [Related]
36. A histopathological evaluation and potential prognostic implications of oral squamous cell carcinoma with adverse features.
Chang WC; Chang CF; Li YH; Yang CY; Su RY; Lin CK; Chen YW
Oral Oncol; 2019 Aug; 95():65-73. PubMed ID: 31345396
[TBL] [Abstract][Full Text] [Related]
37. Histopathological prognosticators and their clinicopathological correlation in oral squamous cell carcinomas of the tongue.
Pallavi K; Tandon A; Gulati N; Juneja S; Shetty DC
J Cancer Res Ther; 2022 Dec; 18(Supplement):S226-S232. PubMed ID: 36510969
[TBL] [Abstract][Full Text] [Related]
38. LIHNCS - Lugol's iodine in head and neck cancer surgery: a multicentre, randomised controlled trial assessing the effectiveness of Lugol's iodine to assist excision of moderate dysplasia, severe dysplasia and carcinoma in situ at mucosal resection margins of oral and oropharyngeal squamous cell carcinoma: study protocol for a randomised controlled trial.
McCaul JA; Cymerman JA; Hislop S; McConkey C; McMahon J; Mehanna H; Shaw R; Sutton DN; Dunn J
Trials; 2013 Sep; 14():310. PubMed ID: 24063578
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.
Shinohara S; Kikuchi M; Tona R; Kanazawa Y; Kishimoto I; Harada H; Imai Y; Usami Y
Jpn J Clin Oncol; 2014 Mar; 44(3):232-40. PubMed ID: 24470584
[TBL] [Abstract][Full Text] [Related]
40. Salvage Transoral Robotic Surgery for Recurrent or Residual Head and Neck Squamous Cell Carcinoma: A Single Institution Experience.
Dabas S; Dewan A; Ranjan R; Dewan AK; Shukla H; Sinha R
Asian Pac J Cancer Prev; 2015; 16(17):7627-32. PubMed ID: 26625773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
